MISGAV, Israel, Nov. 10, 2020 /PRNewswire/ — Limaca Medical, (“Limaca”) a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel– and Singapore-based investment group focused on high-growth medical and agrifood technologies, announced it has closed $1.25 million of a $1.5 million round to complete first-in-human (“FIH”) procedures, post-market clinical studies, and obtain regulatory approvals.
Limaca has raised $1.25 million from Trendlines, Agriline (ultimately owned by a trust of which Vincent Tchenguiz is a discretionary beneficiary), Limaca Chairman and medical device industry veteran Carl Rickenbaugh, and a private investor.
The Precision™ biopsy device developed by Limaca deploys an automated revolving needle to acquire high-quality core tissue for histopathology and advanced genetic profiling. The Precision device makes it possible to acquire biopsy tissue samples at ten times greater procedural efficiency with less trauma than today’s endoscopic standard of care for greater diagnostic accuracy and patient-specific treatment to achieve better clinical outcomes.
Limaca’s CEO Assaf Klein commented, “We designed Precision to improve upon endoscopic biopsies and make a substantial leap forward in this critical diagnostic procedure to advance precision treatment and achieve superior outcomes for cancer patients.”
To date, 10 patients have been enrolled in Limaca’s FIH study at the Rambam Health Care Campus in Israel. The FIH study compares Limaca’s Precision to standard of care EUS biopsy devices. Results have demonstrated excellent ease of use, safety, and improved sample capture. Iyad Khamaysi, MD, Director, Invasive Endoscopy Unit, Rambam Health Care, and one of Limaca’s founders, states, “Precision exceeded all clinical expectations for endoscopic biopsy while demonstrating clear safety in our cases.”
Limaca’s initial market is biopsy sampling for pancreatic cancer, an $850 million opportunity. Current methods used for sampling of this deadly cancer are outdated and provide poor tissue samples, frequently requiring a second biopsy procedure to acquire more tissue for diagnostic testing. Additional markets for Precision, which are estimated at over $400 million, address biopsy sampling for the diagnosis of lung cancer, liver biopsy, lymphoma, and other cancers where endoscopic biopsy is feasible and subcutaneous tissue sampling is difficult.
Carl Rickenbaugh, Limaca’s Chairman, comments “The medical provider and payor markets respond to superior devices when they demonstrate strong clinical relevancy. We built Limaca to address the need for a more efficient endoscopic procedure for the provider, and for the cancer patient and payor, greater certainty to gain sufficient sample quality and quantity needed for pathology as well as more stringent genetic testing requirements.”
Assaf Klein, CEO Limaca Medical
View original content to download multimedia:https://www.prnewswire.com/news-releases/limaca-medical-raises-1-25-million-to-enhance-precision-medicine-through-improved-biopsies-301169885.html
SOURCE Limaca Medical
Fitness Innovator Teams with Leading Fitness Platform to Enhance Customer Training Experience with In-App Exercise Programs
LITTLE CANADA, Minn., Oct. 20, 2020 /PRNewswire/ — As fitness app usage soars, with over 84 million consumers using apps in the US alone, Dragon Door announced they would be making their best-selling fitness content available on the TriadXP fitness platform and TriadXP.com. Dragon Door will use TriadXP to convert their exercise routines into in-app workouts that are performed with the TriadXP app. The app’s voice and visual cues walk exercisers through all exercise routines guiding them on what to do, when, how many, or for how long. With guidance and tracking, customers enhance their training experience and improve workout efficiency. And, since the TriadXP mobile fitness app tracks the user’s performance as they workout with minimal effort on the users part, it eliminates the need for other apps or pen and paper to track results.
“TriadXP supports virtually any kind of workout,” said John Du Cane, CEO of Dragon Door Publications. “As fitness innovators, we know that long-term results are usually the result of consistent goal setting and the consistent measurement of results. You get what you measure for, and the measurement motivates you to maintain your progress. In that regard, we see TriadXP as the perfect solution to help our customers optimize their workout results.”
Addressing the need for home-based and callisthenic workouts, the bestselling 16-week Get Strong program from fitness gurus Al Kavadlo and Danny Kavadlo will be the first program launched.
Dragon Door, credited with launching the modern kettlebell movement, is a publisher and online fitness retailer and provides advanced training and certification for fitness instructors. When searching for a partner who would provide the requisite technology platform from content conversion thru mobile app, Dragon Door found their answer with TriadXP. TriadXP knows fitness technology and delivers an optimal workout experience for a fitness enthusiast. The easy-to-use mobile fitness app and its versatility were critical in the decision. Equally important was TriadXP’s AI-driven conversion tools, which quickly convert content without needing any technical knowledge at Dragon Door.
“We are excited to partner with a leader like Dragon Door,” said Mike Elia, CEO of Triad Fitness Group. “They have a lot of great content, and we know their users will find it easier to work out and perform their routines on our TriadXP app.”
About Dragon Door Publications
Dragon Door Publications is a publisher of innovative fitness content that offers effective, safe, and proven methods for maintaining a high level of health and physical performance over the long-term. The company is best known for having launched the modern kettlebell movement in 2001. Learn more at www.dragondoor.com
TriadXP.com, a fitness content platform from Triad Fitness Group, provides services and technology to allow content providers to convert text-based programs and related exercise imagery and videos into in-app exercise programs to be performed and tracked with the TriadXP mobile app. The app is free and compatible with iOS and Android devices. TriadXP is making workouts better for everyone. Learn more at www.triadxp.com
Contact: John Du